Literature DB >> 30172532

LC-ESI-MS/MS method for simultaneous determination of eleven bioactive compounds in rat plasma after oral administration of Ling-Gui-Zhu-Gan Decoction and its application to a pharmacokinetics study.

Bin Ji1, Yunli Zhao1, Peipei Yu1, Bin Yang1, Ceng Zhou1, Zhiguo Yu2.   

Abstract

A sensitive and robust LC-MS/MS method has been developed and validated to simultaneous determine the concentrations of tumulosic acid, dehydrotumulosic acid, polyporenic acid C, cinnamic acid, Atractylenolide I, Atractylenolide II, Atractylenolide III, glycyrrhizic acid, glycyrrhetinic acid, liquiritigenin and isoliquiritin in plasma from rats who received Ling-Gui-Zhu-Gan Decoction extract oral administration. The samples were prepared by a liquid-liquid extraction procedure using ethyl ether as the extraction solvent and schisandrin as the internal standard. Chromatographic separation was achieved using a Thermo Hypersil GOLD C18 column (2.1 mm × 100 mm, 1.9 µm) and a gradient mobile phase consisting of acetonitrile-water with 0.1% formic acid. All of the analytes were quantified using negative and positive multiple reaction monitoring mode. The method was validated for selectivity, linearity, accuracy, precision, recovery, matrix effect and sample stability under various storage conditions, whose values are all fell in the acceptable limits. We report the lowest limit of quantification for tumulosic acid, dehydrotumulosic acid and polyporenic acid C as 2 ng/mL. This is the first study for simultaneous determination of so many analytes in rat plasma after oral administration of Ling-Gui-Zhu-Gan Decoction. This validated method was successfully used to study the pharmacokinetics of multiple compounds in rat plasma after oral administration of Ling-Gui-Zhu-Gan Decoction.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ling-Gui-Zhu-Gan Decoction; Multiple bioactive compounds; Pharmacokinetics; Rat plasma; UPLC-MS/MS

Mesh:

Substances:

Year:  2018        PMID: 30172532     DOI: 10.1016/j.talanta.2018.08.020

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  8 in total

1.  Exploring the Mechanism of Ling-Gui-Zhu-Gan Decoction in Ventricular Remodeling after Acute Myocardial Infarction Based on UPLC and In Vivo Experiments.

Authors:  Peng Zhou; Meng Zhang; Xiao-Ni Zhao; Tong-Juan Tang; Xiang Wang; Lu-Lu Huang; Qi Kong; Liang Wang; Jin-Ling Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-16       Impact factor: 2.650

2.  An integrated strategy for comprehensive characterization of metabolites and metabolic profiles of bufadienolides from Venenum Bufonis in rats.

Authors:  Wen-Long Wei; Hao-Jv Li; Wen-Zhi Yang; Hua Qu; Zhen-Wei Li; Chang-Liang Yao; Jin-Jun Hou; Wan-Ying Wu; De-An Guo
Journal:  J Pharm Anal       Date:  2021-02-12

3.  Ling-Gui-Zhu-Gan Decoction Protects H9c2 Cells against H2O2-Induced Oxidative Injury via Regulation of the Nrf2/Keap1/HO-1 Signaling Pathway.

Authors:  Xiang Wang; Tongjuan Tang; Mengting Zhai; Ruirui Ge; Liang Wang; Jinling Huang; Peng Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-30       Impact factor: 2.629

4.  Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction.

Authors:  Baolin Li; Shuaishuai Fan; Jingnan Hu; Yongben Ma; Yu Feng; Fengxia Wang; Xinguo Wang; Liying Niu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-22       Impact factor: 2.629

5.  Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.

Authors:  Vladislav V Fomenko; Nadezhda B Rudometova; Olga I Yarovaya; Artem D Rogachev; Anastasia A Fando; Anna V Zaykovskaya; Nina I Komarova; Dmitry N Shcherbakov; Oleg V Pyankov; Andrey G Pokrovsky; Larisa I Karpenko; Rinat A Maksyutov; Nariman F Salakhutdinov
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

6.  The development and validation of an HPLC-MS/MS method for the determination of eriocitrin in rat plasma and its application to a pharmacokinetic study.

Authors:  Luya Li; Rui Feng; Xue Feng; Yuting Chen; Xin Liu; Wenjing Sun; Lantong Zhang
Journal:  RSC Adv       Date:  2020-03-12       Impact factor: 4.036

7.  Assessment of a developed HPLC-MS/MS approach for determining plasma eupatorin in rats and its application in pharmacokinetics analysis.

Authors:  Rui Feng; Luya Li; Xiaowei Zhang; Yuqian Zhang; Yuting Chen; Xue Feng; Lantong Zhang; Guohua Zhang
Journal:  RSC Adv       Date:  2020-08-28       Impact factor: 4.036

8.  Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway.

Authors:  Meng-Yu Zuo; Tong-Juan Tang; Xiang Wang; Jin-Fan Gu; Liang Wang; Jian Chen; Juan Yao; Xiang-Yang Li; Peng Zhou; Jin-Ling Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-14       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.